A cross-disciplinary collaboration seeks to connect the clinic and the laboratory and improve the translation of Alzheimer’s disease research.
News and Highlights
AIDS pioneer Michael Hulton is using WWII art reparations to support Gladstone and advance the fight against HIV
Scientists at the Gladstone Institutes have successfully converted human skin cells into fully-functional pancreatic cells.
With support from the Wilsey Family, Gladstone is studying a rare genetic condition that could provide clues to curing a whole host of diseases.
New findings about Alzheimer’s disease advance the search for more effective treatments.
Thanks to the successful implementation of HIV treatment and prevention programs, we have never been closer to achieving our goal of ending new HIV infections.
amfAR has awarded $20 million to UCSF, the Gladstone Institutes, and the Blood Systems Research Institute to establish the amfAR Institute for HIV Cure Research.
Researchers from the Gladstone Institutes have shown for the first time that the protein BRCA1 is required for normal learning and memory and is depleted by Alzheimer’s disease.
The regenerative medicine program at the Gladstone Institutes has attracted the attention of two global business leaders known for their innovative approach to philanthropy.
The most influential “organ” in the human body is made up of foreign cells—six pounds worth of microorganisms. Katherine Pollard studies the human microbiome to learn how it influences health and disease.